Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
A double-blind, placebo-controlled study to assess the efficacy of adjunctive treatment with LEV 3000mg/day in reducing myoclonic seizures in adolescents and adults suffering from idiopathic generalised epilepsy and to evaluate the safety of LEV in the same population.
Epistemonikos ID: a26900086b0f18fe468f80112e665e328bbde66a
First added on: May 04, 2024